FDA approves TMO’s integrated NSCLC assay including BRAK/ALK/EGFR: http://www.prnewswire.com/news-releases/fda-approves-first-companion-diagnostic-test-to-simultaneously-screen-for-multiple-non-small-cell-lung-cancer-therapies-300478690.html